2022

1. FLT3-ITD Expression as a Potential Biomarker for the Assessment of Treatment Response in Patients with Acute Myeloid Leukemia

   Cancers, Vol. 14, Núm. 16

2. Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC

   Transplantation and Cellular Therapy, Vol. 28, Núm. 4, pp. 204.e1-204.e10